28 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

0A8R

Seagen
US$228.954.6%81.1%US$43.2bUS$229.12PS18.8xE71.8%n/a

0A8K

ImmunoGen
US$31.246.4%658.3%US$8.4bUS$29.16PS29.1xE45.9%n/a

0EVI

Innate Pharma
€2.23-0.2%-18.4%€181.5m€6.23PS2.9xE33.0%n/a

0HOJ

Blueprint Medicines
US$106.2412.2%93.3%US$6.7bUS$118.11PS23.6xE66.3%n/a

0JDK

Iovance Biotherapeutics
US$13.8813.3%95.5%US$3.9bUS$25.99PS3266.7xE61.7%n/a

OXB

Oxford Biomedica
UK£3.2826.2%-21.0%UK£328.0mUK£4.27PS3.7xE101.6%n/a

LLA

LungLife AI
UK£0.300%n/aUK£8.0mUK£2.54PS217.9xE88.7%n/a

0A4W

ACADIA Pharmaceuticals
US$17.38-0.3%-19.5%US$2.8bUS$29.39PS3.9xE40.7%n/a

0IV3

Geron
US$3.76-6.2%36.6%US$2.2bUS$6.11PS4254.6xE64.9%n/a

0H22

BioInvent International
kr26.535.5%-3.6%kr1.8bkr81.69PS29xE81.6%n/a

0A45

Moderna
US$121.318.7%-8.1%US$46.8bUS$137.38PS9.1xE68.7%n/a

0QFD

Moderna
US$115.7611.4%-5.6%US$47.9bUS$131.09PS9.1xE68.7%n/a

ARGXB

argenx
€362.905.4%-0.5%€21.6b€438.71PS18.3xE56.1%n/a

0QW0

argenx
€362.073.7%0.3%€21.6b€437.70PS18.3xE56.1%n/a

XSPRAS

Xspray Pharma
kr50.850%n/akr1.1bkr153.70PB1.7xE221.0%n/a

FYBD

Formycon
€63.300%-11.1%€911.0m€118.80PS13.3xE80.8%n/a

BINVS

BioInvent International
kr34.750%n/akr2.1bkr124.66PS6.7xE64.4%n/a

LLAI

LungLife AI
UK£0.26-13.3%-52.7%UK£8.0mUK£2.20PS217.9xE88.7%n/a

0QT6

Genfit
€3.322.5%-15.5%€161.8m€9.57PS4.7xE54.7%n/a

0JXI

Madrigal Pharmaceuticals
US$235.3814.6%-22.6%US$5.0bUS$376.76PB12.4xE61.4%n/a

0YAY

Vitrolife
kr176.807.0%-23.1%kr24.1bkr230.23PS6.9xE112.2%0.6%

0QCO

Pharming Group
€0.902.3%-21.1%€606.1m€2.00PS2.7xE53.0%n/a

DBVP

DBV Technologies
€3.610%n/a€284.7m€7.52PS59.3xE42.1%n/a

0QAJ

DBV Technologies
€1.22-1.8%-59.4%€115.8m€4.83PS7.9xE53.3%n/a
Page 1 of 2
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.